R Paul Robertson received two NIDDK grants totaling to improve islet transplantation
In 2007, R. Paul Robertson, M.D., at the Pacific Northwest Research Institute, received two grants totaling $3,173,400 from…
-
-
Cocrystal Discovery (Cocrystal Pharma) was founded
In 2007, Cocrystal Discovery, now known as Cocrystal Pharma, was founded in Bothell as a pharmaceutical company with…
-
The CDC responded to a multi-state outbreak of E coli infections
On Dec. 14, 2006, the U.S. Centers for Disease Control and Prevention (CDC) reported a multi-state outbreak of…
-
The Animal Enterprise Terrorism Act was signed into lawﾠ
On Nov. 27, 2006, the Animal Enterprise Terrorism Act (AETA) was officially signed into law by President George…
-
Washington University received its largest grant ever for the Genome Sequencing Center
On Nov. 20, 2006, the Genome Sequencing Center at Washington University School of Medicine in St. Louis announced…
-
Biotechnology | Diagnostics | Disease | FDA | Oncology | Therapeutics | Women's Health
FDA approved trastuzumab for use with other drugs in adjuvant treatment of women with early-stage, node-positive, HER2-overexpressing breast cancer
On Nov. 16, 2006, the U.S. Food and Drug Administration (FDA) approved Genentech’s trastuzumab (Herceptin) for use with…
-
The FDA approved Glivec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) granted Glivec® (imatinib) has received US regulatory…
-
The National Cancer Institute released preliminary data on genetic susceptibility for prostate cancer
On Oct. 19, 2006, the National Cancer Institute released new data from the Cancer Genetic Markers of Susceptibility…
-
The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
On Oct. 19, 2006, the U.S. Food and Drug Administration (FDA) approved the drug, Gleevec developed by Oregon…
-
ICOS Corp announced agreement to be acquired by Eli Lilly
On Oct. 18, 2006, ICOS announced it had signed an agreement to be acquired by Eli Lilly and…
-
Trubion Pharmaceutical completed its IPO
On Oct. 18, 2006, Trubion Pharmaceutical completed its IPO of 4,000,000 shares of common stock at $13.00 per…
-
Biotechnology | Diagnostics | Disease | Genomics | NIH | Oncology | Therapeutics | Women's Health
NIH announced two integral components of the Cancer Genome Atlas Pilot Project
On Oct. 16, 2006, the Cancer Genome Atlas program, created by National Cancer Institute and the National Human…
-
Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for translational research
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
-
National Cancer Institute scientists identified novel protein that ties disruption of critical cellular pathway to Birt-Hogg-Dub syndrome
On Oct 2, 2006, National Cancer Institute researchers have linked specific genetic mutations to defects in cells that…
-
The Virginia Bioinformatics Institute opened new office complex in the National Capital Region
On Sept. 28, 2006, the Virginia Bioinformatics Institute (VBI) at Virginia Tech announced that it will officially open…
-
Biotechnology | Diagnostics | NIH | Oncology
The National Cancer Institute created network of clinical proteomic technology centers for cancer research
On Sept. 27, 2006, the National Cancer Institute announced funding for a major component of its $104 million,…
-
The Allen Institute for Brain Science Completed the Brain Atlas
On Sept. 26, 2006, the Allen Institute for Brain Science announced the completion of the groundbreaking Allen Brain…
-
The OMRF celebrated it’s 60th anniversary
On Sept. 15, 2006, the Oklahoma Medical Research Foundation (OMRF) celebrated it’s 60th anniversary. More than 600 people…
-
Biotechnology | CDC | Diagnostics | NIH | Oncology
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On Sept. 6, 2006, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
-
National Cancer Institute researchers developed a new model for estimating the 5-year risk of melanoma
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
-
Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated
On Aug. 23, 2006, the Sandia Center for Integrated Nanotechnologies facility (CINT) was dedicated. Designed as a national…
-
Corus Pharma was acquired by Gilead Sciences for $365 million
On Aug. 11, 2006, Gilead Sciences announced that it had completed its acquisition of Corus Pharma for $365…
-
The Frances Langford Heart Center opened its doors
On Aug. 1, 2006, the Frances Langford Heart Center opened its doors bringing open-heart surgery and interventional cardiology…
-
Sandia work on space shuttle showed live cells influence growth of nanostructures
On Jul. 20, 2006, Sandia and the University of New Mexico reported that experiments involving single-cell organisms in…
-
Biotechnology | Diagnostics | Disease | Oncology | Radiology | Therapeutics
Alaska Airlines awarded E. Donnall Thomas Medal of Achievement Medal
On Jul. 18, 2006, the Fred Hutchinson Business Alliance announced that the E. Donnall Thomas Medal of Achievement…
-
Eli Lilly and Company’s Gemzar was approved for use in the treatment of women living with recurrent ovarian cancer
On Jul. 17, 2006, Eli Lilly and Company’s Gemzar was approved by the U.S. Food and Drug Administration (FDA) for…
-
Biotechnology | Diagnostics | NIH | Oncology
The National Cancer Institute scientists identified an inherited gene that strongly affects risk for the most common form of melanoma
On Jun. 29, 2006, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health,…
-
ACIP recommends second dose of varicella vaccine for children
On Jun. 29, 2006, the Advisory Committee on Immunization Practices (ACIP) to the Centers for Disease Control and…
-
Johnsonﾠ &ﾠ Johnson acquired Pfizer Consumer Healthcare for $16.6 billion
On Jun. 27, 2006, Pfizer announced that it had reached a definitive agreement to sell its Pfizer Consumer…
-
Biotechnology | Diagnostics | NIH | Oncology
Gene expression profiling can accurately diagnose Burkitt’s lymphoma
On Jun. 7, 2006, gene profiling, a molecular technique that examines many genes simultaneously, can accurately distinguish between…
